Paul Richardson

82PUBLICATIONS
204CO-AUTHORS
Infectious diseasesInfant and child healthMolecular targetsGene and molecular therapyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (82)

|May 12, 2026
Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.

|Jan 13, 2026
Defibrotide for prophylaxis of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) in pediatric high-risk patients: consensus guidelines from the European Society for Blood and Marrow Transplantation (EBMT).

Selim Corbacioglu, Rajinder Bajwa, Ali Bülent Antmen

|Oct 30, 2025
Mezigdomide for multiple myeloma: a focus on phase 2 trial data.

Clifton C Mo, Yuxin Liu, Omar Nadeem

|Sep 03, 2025
The Role of CELMoD Agents in Multiple Myeloma.

Niels W C J van de Donk, Nizar J Bahlis, Charlotte Pawlyn

|Jul 28, 2025
Practical Guidance on Clinical Management of Belantamab Mafodotin-Associated Ocular Events.

Evangelos Terpos, Suzanne Trudel, María-Victoria Mateos

|May 10, 2025
EXCALIBER-RRMM: a phase III trial of iberdomide, daratumumab, and dexamethasone in relapsed/refractory multiple myeloma.

Sagar Lonial, Meletios A Dimopoulos, Jesus G Berdeja

Pageof 14

Frequent Collaborators

19 joint publications

Jacob P Laubach

12 joint publications

Meletios-Athanasios Dimopoulos

9 joint publications

Philippe Moreau

6 joint publications

Peter M Voorhees